Introduction {#S1}
============

Timekeeping in *Drosophila* relies upon transcription-translation feedback loops in which rhythmically expressed clock genes negatively regulate their own expression. In the major loop, the CLOCK-CYCLE (CLK-CYC) heterodimer activates transcription of the *period* (*per*) and *timeless* (*tim*) genes during the day, and in the middle of the night the PER and TIM proteins heterodimerize and enter the nucleus to repress the activity of CLK-CYC^[@R1],[@R2]^. In a second interlocked loop, CLK-CYC activate expression of the *PAR Domain Protein 1 (Pdp1*) ε and *vrille (vri)* genes, which encode an activator and a repressor respectively of the *Clk* gene. PDP1ε activates *Clk* transcription during the late night to early morning^[@R2][@R3]^. However it is important to note that *Clk* mRNA levels are maintained at peak levels even in *Clk^Jrk^* and *cyc^0^* mutants that have very low PDP1, suggesting other transcriptional regulators of *Clk* expression^[@R4]^. In addition, structure-function analyses of the *Clk* promoter suggested that *Clk* expression can be regulated by transcription factors other than PDP1 and VRI^[@R5]^. Taken together these studies implicate other transcription factors in *Clk* expression and possibly in the *Drosophila* molecular clock.

The mammalian circadian clock is generated through similar mechanisms, whereby the negative regulators, CRYPTOCHROME (CRY) and PER, regulate the transcriptional activity of CLOCK and BMAL1 (mammalian ortholog of CYC)^[@R6]^. As in the *Drosophila* clock, the second loop is generated through autoregulation of one of the transcriptional activators, but in this case it is *Bmal1* rather than *Clock*^[@R7]^. Nuclear receptors, REV-ERBα and β are transcriptional repressors of the *Bmal1* gene^[@R8];\ [@R9]^ while RORα is an activator^[@R7]^ and both of these are targets of CLOCK-BMAL1. The closest *Drosophila* homolog of *Rev-Erb* is the nuclear receptor and ecdysone-induced protein, Eip75 (also known as E75)^[@R9];\ [@R10]^. E75 mediates responses to ecdysone during development^[@R11]^ and is also implicated in heme metabolism and signaling of gases such as carbon monoxide (CO) and nitric oxide (NO)^[@R12];\ [@R13]^, ^[@R14]^. However, although some components of the ecdysone signaling pathway are implicated in circadian rhythms^[@R15]^, it's not known if E75 has a role in the *Drosophila* circadian clock.

In the present study, we identified E75 as a component of the *Drosophila* clock through an unbiased gain-of-function genetic screen for novel circadian genes. Overexpression as well as knockdown of *E75* in clock neurons leads to arrhythmic or weak circadian behavior. These manipulations also attenuate the molecular cycling of PER, indicating that they directly impact the molecular clock. We found that E75 acts as a repressor of *Clk,* and is itself subject to inhibition by PER. Thus, we have identified a mechanism for the previously proposed de-repressor function of PER on *Clk* expression^[@R4]^. Given the role of E75 in steroid signaling, which is involved in the response to stress, we also investigated its function under conditions of environmental stress. We found that expression of E75 protects the central clock against environmental stressors.

Results {#S2}
=======

E75 is a novel gene that regulates circadian rhythms {#S3}
----------------------------------------------------

As previously described^[@R16]^, we conducted a genetic screen for new circadian clock genes by over-expressing genes downstream of a randomly inserted EP (enhancer and promoter) element and assaying rest:activity rhythms. Of the 3662 lines screened, one line (NE-30-49-10) contained an insertion in the promoter region of the *E75* gene. This insertion lies upstream of all known isoforms of *E75,* and its expression by the *tim^27^-Gal4* driver (TG^27^) increases expression of *E75* \~3 fold in adult heads ([Supplementary Figure 1A](#SD1){ref-type="supplementary-material"}). This overexpression, which may be even greater in the targeted clock cells, rendered 96% of the flies arrhythmic under constant dark (DD) conditions ([Table 1A](#T1){ref-type="table"}; [Supplementary Figure 1B](#SD1){ref-type="supplementary-material"}). E75 is an ecdysone-induced protein and, as noted above, its closest homolog is REV*-*ERBα in mammals^[@R17]^. Since TG^27^ is expressed very broadly, we next overexpressed *E75* under the control of the *cry*^24^-*Gal4* and *Pdf*-*Gal4* drivers, which are expressed at lower levels and also more specifically in clock cells. *Pdf*-*Gal4*, in particular, is expressed only in the ventral lateral neurons, which are the central clock cells critical for behavior in constant darkness. Overexpression of *E75* by *cry*^24^-*Gal4* resulted in loss of rhythms in 50% of the flies and those that were rhythmic, displayed significantly longer periods as well as weaker rhythms ([Table 1A](#T1){ref-type="table"}; [Supplementary Figure 1B](#SD1){ref-type="supplementary-material"}). *Pdf*-*Gal4* mediated *E75* overexpression also produced a modest increase in period length and significantly reduced rhythm strength. Additionally about 20% of the flies were arrhythmic under these conditions ([Table 1A](#T1){ref-type="table"}; [Supplementary Figure 1B](#SD1){ref-type="supplementary-material"}).

To verify that phenotypes obtained with the NE-30-49-10 insertion were due to overexpression of the *E75* gene, we also over-expressed it using two independent UAS-*E75* transgenes on the 2^nd^ and 3^rd^ chromosomes. *E75* occurs as six different isoforms (see below), and we determined by sequencing that these transgenes overexpress the *RC* isoform. Overexpression *E75* by the TG^27^ driver causes a \~2 fold increase in *E75* mRNA levels ([Supplementary Figure 1A](#SD1){ref-type="supplementary-material"}). The use of the TG^27^ driver with either UAS-*E75* transgene reduced the number of rhythmic flies. However, only TG^27^\>UAS-*E75* (II) flies showed a significant lengthening of period and decreased rhythm strength ([Table 1A](#T1){ref-type="table"}). On the other hand, *Pdf*-*Gal4* driven expression of UAS-*E75* (III) rendered \~25% of the flies arrhythmic although it did not produce a significant effect on other rhythm parameters. The weaker effect of the *Pdf*-*Gal4* driver may be due to its restricted expression or to weaker strength. Regardless, these data support the idea that overexpression of *E75* affects circadian behavior.

We next sought to determine if loss of *E75* impacts circadian rhythms. As null mutations of *E75* are homozygous lethal, we used RNAi to reduce the expression of *E75* in clock cells, and analyzed effects on circadian behavior. We employed four independent lines carrying transgenic RNAi constructs targeted to the common region of *E75*, two from the VDRC collection (GD and KK) and two from the Bloomington stock center (JF02257 and HMS01530). TG^27^ mediated knockdown of *E75* levels led to \~75%, \~25% and \~42% arrhythmicity with JF, KK and GD RNAi lines respectively, while knockdown via HMS RNAi was lethal ([Table 1B](#T1){ref-type="table"}). The GD RNAi lines showed a stronger effect on *E75* transcript levels than KK lines ([Supplementary Figure 1C](#SD1){ref-type="supplementary-material"}). Rhythmic flies for all three viable RNAi lines displayed significantly weaker rhythms and the JF line also yielded a significantly shorter period ([Table 1](#T1){ref-type="table"}). *Pdf*-*Gal4* mediated *E75* knockdown with the GD and JF RNAi lines also significantly reduced rhythmicity, but not circadian period ([Table 1B](#T1){ref-type="table"}). To improve the efficacy of knockdown, we co-expressed *dicer2* with the RNAi constructs. Combining *dicer2* with TG^27^ caused lethality, so we coupled a slightly weaker *tim* driver, *tim*-UAS-*Gal4* (TUG), and *Pdf*-*Gal4* with *dicer2*. TUG\>*dicer2* or *Pdf*-*Gal4*\>*dicer2* mediated *E75* knockdown led to a significant reduction in the number of rhythmic flies, and in most cases also in the strength of rhythmicity, with either the GD or JF RNAi transgene ([Table 1B](#T1){ref-type="table"}).

To map the RNAi phenotype to *E75*, we coupled the RNAi knockdown with genetic mutations of *E75*. Although complete loss of *E75* causes lethality, flies carrying one copy of the null allele (heterozygotes) survive and have normal rhythms ([Table 1B](#T1){ref-type="table"}). For instance, the *E75^Δ51^* strain contains a \~30Kb deletion that removes exons shared by all *E75* isoforms^[@R18]^, and the heterozygotes display robust rhythms ([Table 1](#T1){ref-type="table"}). However, restricted knockdown of *E75* using *Pdf*-*Gal4* in flies heterozygous for *E75^Δ51^* resulted in markedly fewer rhythmic flies than produced by *Pdf-Gal4* in a wildtype background ([Table 1B](#T1){ref-type="table"}), indicating that the phenotype is attributable to loss of E75 function.

As *E75* manipulations had robust effects on circadian behavior, we sought to determine if its expression was regulated in a circadian fashion. *E75* expresses 6 different mRNA isoforms (Flybase), three of which encode the same protein (RB, RE, RF). We designed PCR primers for the four that vary in protein sequence (RA, RB/E/F, RC, RD) and assayed expression at different times of day in adult brains. We detected moderate to robust cycling of four *E75* isoforms in wildtype flies, with no cycling in the arrhythmic mutant *Clk^Jrk^* ([Supplementary Figure 1D--G](#SD1){ref-type="supplementary-material"}), suggesting that expression of *E75* is regulated by the circadian clock. In fact, a recent chromatin immunoprecipitation (ChIP) study indicated that CLK binds directly to the *E75* promoter^[@R19]^.

Alterations in levels of E75 affect the molecular clock {#S4}
-------------------------------------------------------

To determine whether E75 affects molecular clock components, we first examined transcript levels of *per* and *Clk* in whole head extracts of flies overexpressing *E75* (UAS-*E75* II) via the TG^27^ driver. Oscillations of *per* and *Clk* were dampened by *E75* over-expression, in particular through a reduction in peak levels ([Figure 1A and B](#F1){ref-type="fig"}). We also measured PER and CLK protein levels through western blots of whole head lysates and found that these were significantly reduced in *E75* overexpressing flies under LD conditions ([Figure 1C,D and E](#F1){ref-type="fig"}). Similar effects were observed under constant dark (DD) conditions; CLK expression was significantly reduced in flies overexpressing *E75* as compared to the controls ([Supplementary Figure 2A and B](#SD1){ref-type="supplementary-material"}).

Next we examined the effects of knocking down *E75* using the same TG^27^ driver to express UAS-*E75* RNAi (GD) constructs. As shown in [Table 1B](#T1){ref-type="table"}, the GD line in particular led to a strong behavioral phenotype. As predicted by the overexpression data, *per* transcript levels were slightly, although not significantly, increased in flies in which *E75* was knocked down, although PER protein levels were significantly different at ZT08 ([Figure 2A, C and D](#F2){ref-type="fig"}). *Clk* mRNA and protein levels were also significantly higher at specific times of day ([Figure 2B, C and E](#F2){ref-type="fig"}). Notably under these conditions, *per* and *Clk* mRNA cycling did not appear to be affected ([Figure 2A--E](#F2){ref-type="fig"}). As with *E75* overexpression, knockdown had robust effects on CLK expression under freerunning conditions. CLK levels were significantly higher at CT08 and CT14 on the first day of DD in *E75* knockdown flies ([Supplementary Figure 2C and D](#SD1){ref-type="supplementary-material"}).

Clock proteins in adult head extracts are derived largely from the eyes, which do not contribute to the behavioral rhythm. Therefore we also assayed PER levels through immunohistochemistry in circadian behavior-relevant brain clock neurons of flies with reduced levels of *E75*. As the behavioral phenotype produced by *E75* knockdown was somewhat variable (perhaps due to inefficient knockdown), we first selected arrhythmic flies by assaying their behavior and then collected 8--10 flies from each experimental and control group at four different times of day. TG^27^ mediated knockdown of *E75* resulted in dampened cycling of PER in constant darkness in different subsets of clock neurons ([Figure 3A and, B](#F3){ref-type="fig"}). The dampening appeared to arise from significantly higher expression at trough time points (CT8 and CT14) ([Figure 3A and B](#F3){ref-type="fig"}). As the PDF cells are the ones most relevant for free-running behavior, we quantified PER expression in these cells, and found significant differences at CT8 and 14 in the small LN~v~s and at CT8 in the large LN~v~s ([Figure 3C, D](#F3){ref-type="fig"}). PER cycling was also dampened under light:dark (LD) cycles; in fact, under these conditions, PER levels appeared to be relatively higher at all times in LN~v~s and LN~d~s of the *E75* knockdown flies ([Supplementary Figure 3A and B](#SD1){ref-type="supplementary-material"}).

We also assayed CLK levels of LN~v~s by immunohistochemistry under LD cycles in TG^27^ control and *E75* knockdown flies. CLK expression was significantly, although modestly, higher at ZT01 in flies where *E75* had been knocked down ([Supplementary Figure 3C and D](#SD1){ref-type="supplementary-material"}). The small effect on CLK is consistent with the relatively minor shortening of circadian period in these flies ([Table 1](#T1){ref-type="table"}). It is likely that the arrhythmic effects of *E75* knockdown arise from effects on circadian output rather than the molecular clock (see Discussion).

E75 is a transcriptional repressor of the Clk gene {#S5}
--------------------------------------------------

The behavioral and molecular effects of *E75* overexpression and knockdown strongly suggested an important role of this nuclear receptor in the molecular clock. To test for a possible function in the transcription of clock genes, we used cell culture assays. Given that the *Drosophila* E75 and mammalian REV-ERB proteins are so well conserved (\~70%) in their DNA binding domains ([Supplementary Figure 4A](#SD1){ref-type="supplementary-material"}), we first tested E75 for effects on the native mouse *Bmal1* promoter. We transfected *Bmal1-luc* (*Bmal1* promoter fused to luciferase) constructs into HEK293T cells and activated expression using mammalian ROR-α. Upon co-transfection with CMV-*E75*, *Bmal1-luc* activity was significantly reduced \~ 4 fold ([Supplementary Figure 4B](#SD1){ref-type="supplementary-material"}). We then used a reporter construct for *Clk* in which the native promoter of *Clk* (\~ 3.2 Kb) was fused to a luciferase reporter gene^[@R2]^. The *Clk* promoter contains multiple PDP1/VRI and E75 sites, the latter based on their homology to target sites of mammalian REV-ERB proteins, which bind AGGTCA sites in A/T rich regions^[@R20]^. We transfected the *Clk-luc* construct into HEK293T cells and assayed its expression in response to E75. As E75 is known to be a transcriptional repressor, but basal levels of *Clk-luc* are too low to detect further repression, we first activated expression of *Clk-luc* using *Pdp1* (pCDNA3-CMV-*Pdp1 ε*) ([Figure 4A](#F4){ref-type="fig"}). As reported previously^[@R2]^, we saw strong activation of the *Clk* promoter by PDP1ε in a dose dependent manner ([Figure 4A](#F4){ref-type="fig"}). Next we co-transfected these cells with different doses of *E75* (driven by the CMV promoter in pCDNA3.1) and found that E75 strongly repressed *Clk-luc* activity ([Figure 4A](#F4){ref-type="fig"}). To verify that E75 acts on the *Clk* promoter, we constructed an E75-VP16 fusion protein, which is expected to turn E75 into an activator by introducing a VP16 activation domain, and tested its efficacy in regulating *Clk-luc*. We observed an increase of luciferase activity ([Supplementary Figure 4C](#SD1){ref-type="supplementary-material"}), suggesting that E75 binds directly to the *Clk* promoter.

To determine if repression by E75 was specific to *Clk*, we transfected HEK293T cells with a *per*-luciferase reporter, in which luciferase is driven by a 4.6kb fragment of the native *per* promoter that includes E box sites recognized by CLK^[@R21]^. As expected, the 4.6 *per*-luc reporter was activated by CLK; however we failed to detect any repression by E75 ([Supplementary Figure 4D](#SD1){ref-type="supplementary-material"}). On the other hand, PER significantly repressed its own transcription by inhibiting CLK mediated *per* transcription ([Supplementary Figure 4D](#SD1){ref-type="supplementary-material"}). These experiments strongly indicate specific repression by E75 at the *Clk* promoter.

E75 affects transcriptional activity and levels of VRI {#S6}
------------------------------------------------------

*Clk* transcription is also known to be repressed by a well-known bZIP transcriptional factor, VRI, which directly competes with PDP1 to bind at the V/P box^[@R2]^. Interestingly, a genome-wide study aimed at identifying novel molecules induced by ecdysone signaling showed that *vri* expression was significantly increased ^[@R22]^. In a separate study, *vri* expression was found elevated by ecdysone treatment in a tissue culture system^[@R15]^. As *E75* expression is also induced by ecdysone signaling^[@R10]^, we examined whether E75 affects repression of *Clk* transcription by VRI. We used an artificial promoter containing 3 tandem consensus-binding sites for PDP1/VRI, but importantly lacking E75 binding sites, and co-expressed PDP1, VRI and E75. As expected, PDP1 activated *Clk* promoter driven luciferase activity, whereas VRI repressed this activity in a dose-dependent manner ([Figure 4B](#F4){ref-type="fig"}). Interestingly, E75 further repressed expression of this promoter, suggesting that E75 modulates repression by VRI ([Figure 4B](#F4){ref-type="fig"}). To further address whether the two proteins act together to regulate transcription, we used a VRI-VP16 construct to directly activate the artificial *Clk* promoter, and found that the activation was potentiated by E75 ([Supplementary Figure 5A](#SD1){ref-type="supplementary-material"}).

As the experiments above utilized a *Clk* promoter that only contained sites for PDP1/VRI, we asked if direct binding of E75 to its own target sites on the *Clk* promoter could also modulate effects of VRI. Thus, we used a native *Clk* promoter, and found that E75 significantly reduced VRI-VP16 mediated activation of *Clk* ([Supplementary Figure 5B](#SD1){ref-type="supplementary-material"}). These data indicate that E75 can repress *Clk* directly, but probably also affects VRI repression of the *Clk* promoter.

As *vri* expression is increased by ecdysone signaling^[@R22],[@R15]^, we also examined whether E75 affects VRI levels. Knocking down *E75* levels in clock cells significantly reduced VRI levels and overexpression slightly elevated trough levels of VRI*,* indicating that E75 interacts with VRI on multiple levels [Supplementary Figure 5C,D](#SD1){ref-type="supplementary-material"}).

PER interacts with E75 and acts as a de-repressor for Clk transcription {#S7}
-----------------------------------------------------------------------

Low levels of *Clk* mRNA in mutants lacking PER (*per*^01^) are thought to reflect a de-repressor function of PER, in other words suggesting that PER suppresses activity of some repressor^[@R4]^. However, PER is not known to affect VRI-dependent repression of *Clk*, as the effect of VRI on *Clk* expression is similar in wild type and *per* null backgrounds^[@R2]^. Because E75 had robust effects on *Clk* transcription in cell culture assays*,* we asked if PER affects repression of *Clk* by E75.

To address this question, we used the same luciferase based transcription assays in cell culture. As above, the native *Clk-luc* promoter was activated by PDP1ε and repressed by E75, and subsequently PER (driven by the CMV promoter) was added in a dose-dependent manner. Interestingly PER strongly inhibited repression of *Clk* by E75, suggesting that it acts as a de-repressor ([Figure 4A](#F4){ref-type="fig"}). A construct expressing GFP did not affect repression by E75, demonstrating that the de-repression did not result merely from the presence of another transfected protein ([Figure 4A](#F4){ref-type="fig"}). In the absence of E75, PER did not affect transcriptional activity of the *Clk* promoter, supporting the idea that it acts as a de-repressor rather than a co-activator ([Figure 4A](#F4){ref-type="fig"}).

To determine whether E75 and PER physically interact, we co-transfected them into mammalian HEK293T cells as well as into *Drosophila* S2 cells and conducted co-immunoprecipitation assays. E75 tagged with V5 pulled down PER in HEK 293T cells ([Figure 5A](#F5){ref-type="fig"} and [Supplementary Figure 6A](#SD1){ref-type="supplementary-material"}). CRY-V5 also pulled down PER under these conditions, whereas a non-specific GABA-T-V5 (GABA-transaminase fused to a V5 tag) protein did not, indicating specificity of the interaction between E75 and PER and also between CRY and PER ([Figure 5A](#F5){ref-type="fig"} and [Supplementary Figure 6A](#SD1){ref-type="supplementary-material"}). Similar results were obtained in *Drosophila* S2 cells, where PER pulled down V5-tagged E75 ([Supplementary Figure 6B](#SD1){ref-type="supplementary-material"}).

We next determined whether PER contributes to the regulation of *Clk* via E75 *in vivo*. Thus, we examined *Clk* mRNA levels in response to manipulations of E75 in the presence and absence of PER. As reported earlier, we found that *per^0^* flies express relatively low levels of *Clk* mRNA^[@R4]^ ([Figure 5B, C](#F5){ref-type="fig"}). Knockdown of *E75* in a *per^0^* background increased *Clk* mRNA to peak levels in wild type, supporting the idea that E75 keeps *Clk* mRNA low in *per^0^* flies ([Figure 5B](#F5){ref-type="fig"}). In wild type flies, the effect of *E75* knockdown on *Clk* mRNA was restricted to the trough time point and was less than in *per^0^*, perhaps because E75 has limited contribution to *Clk* expression in the presence of the de-repressor PER.

We also assayed *Clk* mRNA levels in wild type and *per^0^* backgrounds under conditions where *E75* was overexpressed with the TG^27^ driver. As noted in [Figure 2](#F2){ref-type="fig"}, overexpression of E75 reduced *Clk* mRNA in wild type flies. In *per^0^* flies also, overexpression of *E75* reduced expression of *Clk* mRNA, although the difference was small, perhaps because *Clk* levels were already low ([Figure 5C](#F5){ref-type="fig"}). The effect of knockdown and overexpression of E75 on *Clk* mRNA levels in a *per^0^* background indicate that endogenous PER affects E75 action at the *Clk* promoter.

To further analyze the genetic interaction between PER and E75, we also compared CLK protein levels in wild type and *per^0^* genetic backgrounds, following over-expression or knockdown of *E75*. Knockdown of *E75* increased CLK protein in wild type and *per^0^* flies, but in these experiments the difference was significant only in *per^0^* (note that there is variability in the effect on CLK), again supporting the idea that E75 contributes more to CLK expression in *per^0^* flies. However, the increase in the protein was not as great as in the mRNA, suggesting that other factors keep CLK low in *per^0^* flies. Over-expression of *E75* resulted in a greater overall reduction of CLK in a *per^0^* background than in wild type, again most likely because CLK levels are already low in *per^0^* ([Figure 5D, E](#F5){ref-type="fig"}).

Ecdysone signaling regulates circadian behavior {#S8}
-----------------------------------------------

Previous studies have reported that steroid hormone signaling induces E75 expression to regulate critical developmental processes^[@R23];\ [@R24]^. However ecdysone signaling is also present in adult stages, and mutations that alter hormone or receptor levels affect diverse processes such as behavior, stress resistance, reproduction, and lifespan^[@R11]^. In fact, disruption of ecdysone signaling has been associated with alterations in circadian behavior and in sleep^[@R15];\ [@R25]^. Therefore we assayed effects of manipulating ecdysone signaling specifically in clock neurons on rest:activity rhythms and on the molecular clock.

We first established that the ecdysone receptor (EcR) is expressed in circadian neurons. EcR has three isoforms A, B1 and B2, which differ in their N termini^[@R26]^. We obtained antibodies to EcR isoforms and verified that they recognize these specific proteins, based on their reduced levels in EcR RNAi lines and increased levels in flies that over-express EcR (data not shown). The EcR-A antibody is specific for EcR-A isoform, and the EcR-C antibody is known to detect all 3 isoforms of EcR^[@R27]^. Through immunohistochemistry experiments, we identified distinct expression of the EcR-A specific isoform and perhaps other isoforms (as detected by EcR-C) in adult LN~v~s as well as in the 3^rd^ instar larval stage ([Figure 6A, B](#F6){ref-type="fig"}). To alter EcR activity in clock cells, we utilized RNAi, dominant negative and overexpression approaches, as null mutations of *EcR* are lethal. The dominant negative form of EcR (EcR^Δ^) cannot be activated by ecdysone and interferes with the activity of endogenous EcR, leading to deficiencies in EcR function^[@R26]^. Expression of EcR-B1^Δ^ by *Pdf*-*Gal4* resulted in a significant increase in period and decreased rhythm strength ([Table 2A](#T2){ref-type="table"}). Using TUG, UAS-EcR-B1^Δ^ was expressed in broader sets of clock cells, and resulted in a much longer period (\~26 hrs) and \~ 30% arrhythmicity, but surprisingly less of an effect on the strength of rhythms in rhythmic flies ([Table 2A](#T2){ref-type="table"}). We also expressed EcR-B1^Δ^ using the even stronger clock cell *Gal4* (TG^27^), which resulted in 100% lethality. As reported by Itoh et al^[@R15]^, knockdown of *EcR* using RNAi also yielded circadian phenotypes. *EcR-A* RNAi in PDF positive cells did not alter period but significantly reduced rhythm strength ([Table 2A](#T2){ref-type="table"}). On the other hand, *EcR-A* RNAi using the TUG driver led to a significantly longer period ([Table 2A](#T2){ref-type="table"}), although again, with less of an effect on rhythm strength.

We also overexpressed different isoforms of the *EcR* gene using *Pdf* --*Gal4* and TG^27^ drivers. *Pdf*-*Gal4* mediated overexpression of the different isoforms produced phenotypes of varying strength, with two isoforms (A and B2) reducing rhythm strength and one (A) also reducing the number of rhythmic flies ([Table 2B](#T2){ref-type="table"}). TG^27^ mediated overexpression of *EcR-A*, *B2* and C, which expresses a common region from all three isoforms of *EcR*, i.e, A, B1 and B2^[@R26]^, resulted in phenotypes that included significantly longer periods, reduced rhythm strength and increased arrhythmia ([Table 2B](#T2){ref-type="table"}). However, the effects varied somewhat from one isoform to the other ([Table 2B](#T2){ref-type="table"}).

EcR is a well-known transcription factor regulating E75 levels, and so it likely contributes to E75 expression in clock cells^[@R28]^. We assayed the levels of different isoforms of E75 in the brains of flies where EcR-B1 levels were knocked down. Consistent with previous findings, we found that E75-RA, RB and RC isoforms were reduced by knockdown of EcR ([Supplementary Figure 7A](#SD1){ref-type="supplementary-material"}). *EcR* knockdown also increased CLK expression, although the effects were milder than seen with *E75* reduction ([Supplementary Figure 7B and C](#SD1){ref-type="supplementary-material"}), perhaps because EcR can affect *Clk* in multiple ways through different signals^[@R15]^. These data indicate though that effects of EcR, like those of E75, are not going solely through the molecular clock (see Discussion).

E75 protects the central clock under conditions of stress {#S9}
---------------------------------------------------------

In adults, ecdysone signaling is increased upon exposure to stressful environments^[@R25];\ [@R29]^. As *E75* is a direct target of EcR, we asked if signaling through E75 is important in the presence of environmental stressors. To test this idea, we subjected adult flies to two different stressful conditions that are known to increase ecdysone signaling: low nutrition and high temperature^[@R30];\ [@R31]^. For nutritional stress we varied the amount of sucrose (1%, 2% and 5%) in the 2% agar medium (see methods for details), whereas for temperature stress we tested temperatures of 25°C (regular), 28°C and 32°C.

Control flies (iso31 or UAS/Gal4 alone) did not show changes in circadian period upon temperature or nutritional stress ([Table 3](#T3){ref-type="table"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}) and for the most part they remained rhythmic, although the lines carrying the drivers alone showed some loss of rhythm. Environmental stressors (temperature and nutritional) produced a much stronger effect when *E75* was knocked down in all clock neurons (TUG\>*E75* RNAi), with flies displaying increased arrhythmia ([Table 3B](#T3){ref-type="table"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}). Notably the period of the rhythmic flies did not change significantly even with *E75* knocked down ([Table 3B](#T3){ref-type="table"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}). We also used *Pdf*-*Gal4; dicer2* to knock down *E75* levels under these two conditions, and observed a significant decrease in FFT values (i.e, rhythm strength) and number of rhythmic flies ([Table 3B](#T3){ref-type="table"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}).

To exclude the possibility that any manipulation of the clock renders it more sensitive to environmental stressors, we subjected a *Clk* allele, *Clk^hypo^*, which has dampened molecular oscillations and a long period (\~ 26.5 hrs) (unpublished observations; see Methods for details regarding the lesion), to the same stress conditions. \~60--70% of the *Clk^hypo^* flies remained rhythmic under low nutrient or high temperature conditions ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}). Thus, the effect of the stressors was specific for flies that had low levels of E75. To test whether EcR also impacts the circadian clock under stressful conditions, we assayed locomotor activity rhythms of flies in which EcR had been knocked down under high temperature conditions. As with E75 knockdown, a reduction in EcR levels (A and B1 isoforms) in clock cells led to weakened rhythm strength as well as increased arrhythmicity under conditions of stress ([Supplementary Table 3](#SD1){ref-type="supplementary-material"}). Importantly, control flies and flies with reduced E75 had similar responses to stress in terms of locomotor activity levels, lifespan and food intake ([Supplementary figure 8](#SD1){ref-type="supplementary-material"}). Taken together these data suggest that ecdysone signaling promotes maintenance of rhythms under stressful conditions without significantly affecting daily activity levels, food consumption and longevity.

Discussion {#S10}
==========

We report here that E75, a nuclear hormone receptor induced by ecdysone signaling in *Drosophila,* regulates circadian behavior. This finding was based upon an unbiased, forward genetic screen, in which E75 stood out as a robust modulator of behavioral rhythms. Although the focus of this study is on rest:activity rhythms, which are controlled by the central clock in the brain, the western blot data suggest that E75 is also a component of peripheral clocks in the head. It is likely that not just E75, but ecdysone signaling in general impacts peripheral circadian function. We have also identified a molecular mechanism by which E75 affects the clock. Finally, we show that, in addition to its role in the clock under normal conditions, E75 protects the clock in times of stress. The latter may be related to its function in a steroid-signaling pathway.

In vertebrates, the closest homologs of E75 are members of the REV-ERB family. While REV-ERB is a part of the mammalian clock mechanism, the *Drosophila* ortholog, i.e. E75, was previously not known to have a circadian function. Here we show that E75 is an inhibitor of *Clk* transcription, by itself and also in conjunction with VRI. Prior to this work, it was thought that the role of nuclear hormone receptors in mammalian clocks was served by PAR domain containing proteins, PDP1 and VRI, in *Drosophila*^[@R2]^. Thus, while REV-ERB and ROR regulate expression of *Bmal1* in mammals, PDP and VRI regulate expression of the other transcriptional activator, *Clk*, in flies. Our data indicate that E75 does indeed function in the *Drosophila* clock, much as its mammalian counterpart does ([Figure 6C](#F6){ref-type="fig"}). One may ask why E75 is required if the second feedback loop is maintained by PDP1 and VRI. We suggest that E75 couples the clock to extracellular cues. Induction of E75 by the steroid hormone, ecdysone, likely allows the clock to respond to endocrine signals and perhaps other ligands (further discussed below). As reported here, E75 signaling may be particularly relevant under conditions of stress.

Tissue culture experiments do not indicate a direct effect of E75 on *per* expression, although we cannot exclude the possibility that it does so in flies, as suggested by the robust effect of *E75* overexpression on *per* mRNA and protein levels ([Figure 1](#F1){ref-type="fig"}). However, E75 interacts with PER to regulate transcription of *Clk*. Indeed, this work reveals a new role for *Drosophila* PER as a de-repressor. As noted above, earlier studies showed that PER promotes expression of *Clk*, but the underlying mechanisms were not identified. We find that it does so by reducing the inhibitory effect of E75 on CLK. It may do so by affecting DNA-binding of E75 or perhaps even by destabilizing it. Regardless, these data are reminiscent of mammalian PER, which acts as a de-repressor with some nuclear receptors and a co-activator with others^[@R32]^. Indeed, mammalian PER2 and REVERB**-**α physically interact^[@R32];\ [@R33]^, as we show here for PER and E75. We suggest that crosstalk between components of the two loops is a conserved mechanism that serves to maintain a robust cycle. On the one hand *Drosophila* PER inhibits activity of the CLK/CYC complex to generate a negative feedback loop; meanwhile, it interacts with nuclear hormone receptors like E75 to promote *Clk* gene expression in the positive feedback loop. Although this study only examined effects of PER on E75-mediated repression of CLK, it is likely that there are other circadian targets of E75 that are modulated by PER. Future studies should help to clarify the extent to which E75 impacts transcription within the circadian network. Importantly, the data on E75 presented here provide insight into some of the unresolved questions in the clock field--- for instance, why *Clk* mRNA levels are low in *per^0^* flies.

While E75 appears to act as a component of the molecular clock, its effects on behavior are probably not going entirely through the clock. Knockdown of E75 increases *Clk*, which typically shortens period^[@R34]^, but does not cause arrhythmia. Along the same lines, *per* rhythms dampen, but are not eliminated upon E75 knockdown, and this dampening is not expected to render flies arrhythmic. We suggest that effects of E75 on circadian period are mediated by *Clk*, but in addition E75 affects circadian output, which accounts for the arrhythmia caused by knockdown. As mentioned above, E75 may affect the transcription of other genes, perhaps even in a circadian fashion. We suggest that *E75* is regulated by the clock, which is supported by experiments showing direct binding of CLK to the *E75* promoter^[@R19]^.

Although this is the first report of an ecdysone-induced nuclear receptor in the *Drosophila* central clock mechanism, ecdysone signaling has been previously linked to circadian function. *Early gene at 23* (*E23*), which suppresses the response to ecdysone, is required for normal circadian rhythms in *Drosophila*^[@R15]^. E23 encodes a membrane-bound ABC transporter that is induced by ecdysone in central clock neurons, and its knockdown in these neurons (LN~v~s) increases expression of the clock gene, *vrille,* and lengthens circadian period^[@R15]^. The relationship between E75 and E23 is not known; it is possible that ecdysone signaling activates both molecules, which then have independent effects on the clock. Alternatively, effects of E75 (overexpression and knockdown) on VRI expression as well as cell culture data indicate that E75 may also regulate VRI to modulate *Clk* expression and circadian behavior. Importantly, disruption of EcR signaling also affects rhythms. Loss of EcR can have developmental effects on clock cells^[@R35]^. but we note that many of our manipulations of *EcR* change circadian period without causing arrhythmia, indicating a more specific effect on clock function. Both EcR and E75 are required to maintain rhythmicity under conditions of stress, perhaps through modulation of clock molecules and circadian output.

Of the \~18 known nuclear receptors in *Drosophila*,^[@R36]^ only one other, *unfulfilled*, has been implicated in clock function^[@R37]^. However, the mechanism by which it affects the clock is unknown, as is the ligand that activates it. In case of E75, a few natural ligands have been identified such as heme, CO and NO^[@R13];\ [@R12]^. REV-ERB also binds to heme and may reset the clock in response to it^[@R38]^. It is possible that NO and CO also affect the clock. Future studies of E75 in *Drosophila* could elucidate mechanisms by which nuclear receptors mediate effects of signaling molecules on circadian clock function.

Materials and Methods {#S11}
=====================

Fly Stocks {#S12}
----------

*tim*-Gal4^27^, (TG^27^), *cry*^24^-Gal4, *Pdf-*Gal4 UAS-*E75* RNAi (JF02257 and HMS01530), UAS-*EcR* B1**^Δ^**^C655.F645A^, UAS-*EcR* A-RNAi, UAS-*EcR*-A, UAS-*EcR* B2 and UAS-*EcR*-C, *E75***^Δ51^** and *Clk^hypo^* lines were provided by the Bloomington stock center. *Clk^hypo^* carries a Piggybac {WH}f06808 insertion in the 2^nd^ exon of *Clk* gene and our behavioral and molecular analyses suggest that it's a hypomorphic allele of *Clk* (unpublished data). UAS*-E75* II and III were provided by Henry Krause (University of Toronto). UAS-*E75* RNAi GD and KK were obtained from the Vienna *Drosophila* Stock Center. UAS*-E75* II and III were provided by Henry Krause (University of Toronto). TUG; UAS-*Dicer-2* and *Pdf-*Gal4; UAS-Dicer-2 lines were from our laboratory. NE30-49-10 EP was an overexpression line generated in our laboratory^[@R16]^. The insertion was determined by Inverse PCR in accordance with protocols from the Berkley *Drosophila* Genome Project. *Clk^hypo^* is a Piggybac {WH}f06808 insertion line and was obtained from Bloomington stock center. This element is inserted in the 2^nd^ exon of *Clk* gene and our behavioral and molecular analyses suggest that it's a hypomorphic allele of *Clk* (Kyunghee Koh, personal communication-).

Locomotor Activity Assay {#S13}
------------------------

About 3--5 day old adults were entrained to light: dark (12h:12h) cycles for 3 days at 25°C and then were transferred into constant darkness (DD) and their activity was monitored for at least 6--7 days using the *Drosophila* Activity Monitor (DAM) system (Trikinetics). Data were obtained and analyzed using Clocklab software (ActiMetrics, IL). The periodicity and the strength of the activity:rest rhythm of each fly was determined by visual examination of activity records and chi-square periodograms and through fast Fourier transform (FFT) analysis. Flies displaying distinct single well-defined peaks by chi-square periodogram and an FFT value of \>0.01 were classified as rhythmic individuals and were included for determining the average period and rhythm strength. Individuals with multiple or broad peaks in the periodogram analysis were not counted for period determination, while those that showed random activity patterns and no clear peak by periodogram were categorized as arrhythmic. Note that rhythm strength (FFT values) was calculated only for rhythmic individuals.

Western Blot Analysis {#S14}
---------------------

Western blot assays were performed as previously described^[@R39]^. Briefly 4--5 day old flies were entrained in LD 12:12h cycles for 3 days. Exactly 10 heads were collected on dry ice at indicated time points. For constant dark (DD) experiments, the flies were sampled on the second day. The fly heads were lysed in a homogenization buffer containing 10 mM HEPES \[pH 7.5\], 100 mM KCl, 1 mM EDTA, 10% Glycerol, 0.1% Triton X-100, 5 mM DTT and 5 mM PMSF along with the phosphatase inhibitors okadaic acid and 1 mM sodium vanadate. A protease inhibitor cocktail (Boehringer) was also added to the buffer according to the manufacturer's instructions. Homogenates were spun twice for ten minutes at 12000 rpm, and the supernatant was transferred to microcentrifuge tubes kept on ice. 15μl of each sample was run on 4--12% SDS-polyacrylamide mini-gels, and transferred onto nitrocellulose membranes overnight. PER protein was detected with a 1:2000 dilution of GP anti-PER antibody^[@R40]^. For protein extraction, three to five old adult flies were entrained to 12h: 12h LD cycles for 3 days, and at indicated time points, exactly 10 heads were collected on dry ice. The primary antibodies used in different assays were guinea pig anti-CLK (1:3000)^[@R41]^ and mouse anti-HSP70 (1:15000; Sigma). The western blots were developed by a horseradish peroxidase (HRP) enzymatic activity based assay followed by enhanced chemiluminescence (ECL reagent; Thermo Scientific). These antibodies were highly specific with the most intense band detected at approximately 150 kDa, the predicted size of *Drosophila* PER. Blots were stripped using a western blot recycling kit (Thermo Scientific) and re-probed with a guinea pig anti- CLK antibody (1:3000). Images were obtained using a Kodak image station or through exposure to X-ray film. These images were analyzed by ImageJ software (NIH) for quantification of individual bands.

Quantitative real-time PCR {#S15}
--------------------------

Protocols for total RNA isolation and cDNA synthesis have been described previously^[@R39]^. Briefly, three to five day old adults were entrained to an 12h: 12h LD cycle for 3 days at 25°C and then collected on dry ice at indicated time points on the last day of the LD cycle. Total RNA was isolated using the manufacturer's protocol (TRIzol; Life Technologies), and cDNAs were synthesized using a high-capacity cDNA reverse Transcription kit (Applied Biosystems; Life technologies). Real-time assays were performed using an ABI prism 7000 with a SYBR Green kit (Applied Biosystems). The oligos used in the assays were *Act5C* forward (5′-ATGTCACGGACGATTTCACG-3′) and *Act5C* reverse (5′-CGCGGTTACTCTTTCACCA-3′), *per* forward (5′-CGTCAATCCATGGTCCCG) *per* reverse (5′-CCTGAAAGACGCGATGGTG-3′), *Clk* forward (5′-GGATGCCAATGCCTACGAGT-3′), *Clk* reverse (5′-ACCTACGAAAGTAGCCCACG-3′).

Immunohistochemistry {#S16}
--------------------

Three to five day old adults were entrained to an 12h: 12h LD cycle for 3 days at 25°C and then collected at indicated time points. Adult fly heads were washed in 70% alcohol and brains were dissected in 4% PFA (made in Phosphate buffer saline) and fixed for \~20 min, washed for 1 h in PBS buffer, and followed by overnight incubation with primary antibody (in PBS buffer with 3% normal donkey serum and 0.3% Triton X-100) at 4°C. Brain samples were washed 4--5 times with PBS-T (PBS with 0.3% Triton-X) buffer and incubated with Cy3 donkey anti-rabbit (or guinea pig) and FITC or Cy3 donkey anti rabbit (or mouse) secondary antibodies (Jackson ImmunoResearch Laboratories) for 2 hrs at room temperature, followed by an additional 4--5 washes in PBS-T buffer. A Leica TCS SP5 confocal microscope was used to obtain the fluorescent images. The primary antibody dilutions used in this assay were as follows: PER, 1:1000, CLK (GP50), 1;1000; PDF, 1:1000, mouse EcR common (Ag10.2) 1: 1:50, mouse EcR-A (15G1a) 1:50. Secondary antibody dilutions were 1:500. The fluorescent intensity of individual cells was measured from confocal images with NIH ImageJ software. The background intensity from the adjacent area was subtracted from these values followed by averaging of the normalized value.

Expression Constructs {#S17}
---------------------

For co-transfection studies, the *Clk*-luc^[@R2]^ and 4.6 kb *per*-luc plasmids were generated by inserting genomic DNA upstream of the basal promoter in the luciferase reporter vector pGL3 (Promega). cDNA templates for *E75*, kindly provided by Carl Thummel (University of Utah), were used for constructing the expression vectors pMT-*E75A* and pMT-*E75B*, which contain full-length *E75-RA* and *E75-RC* respectively in the *Not*I and *Xba*I sites of pMTv5HisA (Invitrogen). All constructs were verified by sequencing.

Cell Culture luciferase assay {#S18}
-----------------------------

For the luciferase reporter based transcriptional assays, either human embryonic kidney (HEK-293T) cells were used. For HEK 293T cell transfection assays a total \~ 10^5^ cells were transfected in 24-well plates with the following expression plasmids- CMV-*E75*, CMV-*pdp1ε*, CMV-*per*-HA, CMV-*GFP*- together with the reporter *Clk*-*luc* and the *renilla*-luciferase as internal control. Empty pcDNA3.1 vectors were added to control for uniform DNA amounts across transfections using Lipofectamine (LifeTechnologies). A total of 500ng of DNA was used in each case. Following transfection the cells were harvested after 48 hrs, lysed and assayed for luciferase activity (Promega). The firefly luciferase measurements were normalized to *renilla* luciferase activity counts and presented as a ratio. Transfections were conducted as four independent sets and final values were determined by averaging the data obtained from the four replicates.

Co-Immunoprecipitation assays {#S19}
-----------------------------

Mammalian HEK293T cells (\~2 × 10^6^) were used were transfected with the following plasmids- pcDNA3-*per*-HA, pcDNA3.1 *E75*, pcDNA3-*cry*, pcDNA3.1 *Gaba-t* using Lipofectamine (Life Technologies) reagent and cells were harvested and lysed after 48hrs. In all cases exactly 300 ng of total DNA was transfected. Cell lysates were incubated overnight with primary antibody (HA or PER antibody) and 30 μl of Dyna beads (LifeTechnologies) in IP buffer (10 mM HEPES \[pH7.5\], 150 mM NaCl, 1mM EDTA, 1mM DTT, 0.3% Triton-X 100, 0.03% SDS and protease inhibitor). The beads were washed extensively in wash buffer, followed by SDS-PAGE and Western blotting.
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![Effect of *E75* overexpression on the expression of *per* and *Clk* in adult heads\
**(A)** *per* mRNA expression in TG^27^ controls and TG^27^ \>UAS-*E75* (II) flies during the indicated phases of an LD cycle. **(B)** *Clk* mRNA expression in TG^27^ controls and TG^27^ \>UAS-*E75* (II) flies under LD cycle. **(C)** PER and CLK levels in the genotypes indicated above. A representative western blot is shown. PER and CLK levels are significantly lower in the TG^27^ \>UAS-*E75* (II) flies than in TG^27^ control flies particularly at peak time points. HSP70 antibodies are used to control for loading. Quantification of four independent experiments shows significantly decreased **(D)** PER and **(E)** CLK levels in TG^27^ \>UAS-*E75* (II) flies relative to the TG^27^ control flies. Asterisks above the bars denote significant differences between genotypes. (\*) *P* \< 0.05 using unpaired Student's *t*-test. Error bars depict SEM. A molecular marker (Precision Plus Protein^™^ Dual Color Standards) was run to detect the exact molecular size of different proteins.](nihms639102f1){#F1}

![Effects of *E75* knockdown on the expression of *per* and *Clk* in adult heads\
**(*A*)** *per* mRNA expression in TG^27^ controls and TG^27^ \>UAS-*E75* RNAi (GD) flies at the indicated time points of an LD cycle. **(B)** *Clk* mRNA expression in TG^27^ controls and TG^27^ \>UAS-*E75* RNAi (GD) flies under LD cycle. **(C)** PER and CLK levels in the same genotypes as above. A representative western blot is shown. HSP70 antibodies are used to control for loading. Quantification of six independent experiments shows **(D)** PER and **(E)** CLK levels in TG^27^ \>UAS-*E75* RNAi (GD) flies and TG^27^ control flies. Asterisks *above* the bars denote significant differences between genotypes. (\*) *P* \< 0.05 using unpaired Student's *t*-test. Error bars depict SEM. A molecular marker (Precision Plus Protein^™^ Dual Color Standards) was run to detect the exact molecular size of different proteins.](nihms639102f2){#F2}

![Knockdown of *E75* increases PER expression in brain clock cells\
Flies from TG^27^ and TG^27^\> *E75* RNAi genotypes were tested for their circadian behavior under DD conditions on 6^th^ day and 8--10 rhythmic TG^27^ controls and 8--10 arrhythmic *E75* knockdown flies were used for IHC at each of the indicated time points. PER expression at different times of day in TG^27^\>UAS-*E75* RNAi (GD) flies and TG^27^ controls in the **(A)** small and large LN~v~s and **(B)** Dorsal LNs (LN~d~s). Quantification of PER staining from **(C)** s-LN~v~s and **(D)** l-LN~v~s subset of neurons in the TG^27^ \>UAS-*E75* RNAi (GD) flies (n=10) relative to TG^27^ control flies (n=9). Asterisks *above* the bars denote significant differences between genotypes. (\*) *P* \< 0.05 using unpaired Student's *t*-test. Error bars depict SEM. Time is indicated as CT (circadian time) where CT0 is 12h after lights-off of the last LD cycle. Scale bar = 10 μm.](nihms639102f3){#F3}

![E75 represses transcriptional activity of the native *Clk* promoter\
**(A)** Mammalian HEK-293T cells were transfected with *Clk*-luc (50ng) and *renilla*-luc (10ng) reporter (internal control) and with increasing doses of CMV-*Pdp1ε* (10 and 50 ng) or CMV-*E75* (50, 100, and 250 ng) and in some cases with CMV-*per* (10, 50, 100 ng). The (+), (++) and (+++).denote 10, 50, and 100 ng of DNA respectively, except for the empty pCDNA3.1 vector. Additionally, CMV-*gfp* (10, 50, 100 ng) was used a control for *per*. The firefly luciferase activity was normalized to *renilla*-luc activity, and the fold induction (Y axis) was based upon comparisons with 10 ng of CMV expression vector alone transfections. Data represent an average of four experiments each performed in duplicate. Error bars depict standard error of the mean. C3m-TK luc (a mutant promoter, which cannot be activated by PDP1), was used as an additional control. PDP1 ε and E75 significantly activated and repressed *Clk*-luc respectively, compared to empty vector pCDNA3.1 controls. PER significantly de-repressed the E75 mediated repression of *Clk* promoter repression. **(B)** An artificial promoter, C3-*TK* luc, was used instead of the native *Clk*-luc promoter to determine if E75 acts as a co-repressor with VRI. C3-*TK* luc contains 3 tandem consensus binding sites for PDP1/VRI but none for E75. Other details, including the dosage used, are same to panel **(A)**. PDP1 activates this promoter in a dose dependent manner, and this is repressed by VRI. The highest dose of E75 enhances repression by VRI. (\*p \< 0.05. Two-way ANOVA, Tukey's test post-hoc comparison).](nihms639102f4){#F4}

![PER interacts with E75 to de-repress expression of the *Clk* promoter\
**(A)** Co-immunoprecipitation assay showed that PER physically interacts with E75. 100 ng of CMV-*per* HA was transfected with 200 ng of CMV-*E75* V5 (with two different isoforms RC and RA), CMV-*cry* V5, CMV-*GABA-Transaminase* (GABAT) V5 and empty CMV vector. Anti-V5 antibody was used to pull down protein complexes. PER specifically binds with CRY but not with GABA-T, PER also binds strongly with E75-RC. The RA isoform was poorly expressed, hence weaker interaction with PER (lane 5 in IP: αV5). **(B)** Knockdown of *E75* increases *Clk* mRNA expression in wild type and *per^0^* flies. As in [Figure 2](#F2){ref-type="fig"}, *E75* knock down by TG^27^ significantly increases *Clk* mRNA levels in wild type flies relative to TG^27^ controls at ZT14. This effect is more striking in *per^0^* flies where baseline *Clk* mRNA levels are quite low. **(C)** Overexpression of *E75* reduces *Clk* mRNA expression in wild type and *per^0^* flies. As in [Figure 1](#F1){ref-type="fig"}, *E75* overexpression by TG^27^ significantly decreases *Clk* mRNA levels in wild type and *per^0^* flies relative to TG^27^ controls at ZT02. **(D)** CLK levels in TG^27^ control, TG^27^ \>UAS-*E75* RNAi (GD) and TG^27^ \> UAS-*E75* (II) in wild type and *per^0^* backgrounds are shown for two time points. HSP70 antibodies are used to control for loading. Molecular marker (Precision Plus Protein^™^ Dual Color Standards) were run to facilitate detection of different proteins. **(D)** Quantification of four independent western blots is shown. Asterisks above the bars denote significant differences between genotypes. (\*) *P* \< 0.05 using unpaired Student's *t*-test. Error bars depict SEM and indicate variability across flies of a specific genotype.](nihms639102f5){#F5}

![Incorporating EcR and E75 in the molecular clock\
EcR is expressed in clock cells of larval (**A**) and adult brains **(B)**. EcR is detected with two different mouse anti-EcR antibodies (EcR-A and EcR-C) and PDF is stained with a rabbit anti-PDF antibody. EcR-C antibody detects all isoforms of EcR (A, B1 and B2), whereas EcR-A detects the RA specific isoform of EcR. Scale bar = 10μm. **(C)** Model for the role of E75 in the *Drosophila* molecular clock. E75 represses *Clk* transcription, and this repression is inhibited by PER, which thus acts as a de-repressor of *Clk*. PER can also modulate *Clk* expression through VRI (as VRI is a transcriptional target of CLK, which is regulated by PER), but this is not shown here for the sake of simplicity. In addition, E75 also regulates VRI expression in such a way that overexpression or knockdown of E75 increases or reduces the VRI levels respectively, thus indirectly affecting the CLK expression. Under stress (nutritional and temperature) conditions, E75 is required to maintain robust rhythms.](nihms639102f6){#F6}

###### 

Circadian behavior of flies with altered E75 expression levels under DD conditions

  \(A\)                                                                             
  ------------------------------------------- ---------------- -------------------- ---------------------
  TG^27^                                      93.75 (64)       24.16 ± 0.07         0.048 ± 0.005
  *Pdf*                                       95.08 (61)       24.03 ± 0.08         0.062 ± 0.004
  *cry*^24^                                   87.50 (24)       24.12 ± 0.12         0.068 ± 0.007
  NE30-49-10                                  96.82 (63)       23.65 ± 0.25         0.083 ± 0.003
  UAS*-E75* (II)                              93.75 (32)       23.32 ± 0.64         0.076 ± 0.009
  UAS-*E75* (III)                             96.87 (32)       23.67 ± 0.14         0.092 ± 0.003
  TG^27^\>NE30-49-10                          **4.20** (72)    **25.64 ± 0.35**\*   **0.018 ± 0.003**\*
  TG^27^\> *E75* (II)                         **33.87** (62)   **25.54 ± 0.54**\*   **0.031 ± 0.004**\*
  TG^27^\> *E75* (III)                        **60.86** (31)   24.38 ± 0.24         0.087 ± 0.007
  *Pdf*\>NE30-49-10                           80.60 (62)       **24.53 ± 0.23**\*   **0.035 ± 0.007**\*
  *Pdf\>E75* (II)                             90.32 (31)       24.47 ± 0.45         0.078 ± 0.005
  *Pdf\>E75* (III)                            73.91 (23)       24.35 ± 0.21         0.054 ± 0.009
  *cry*^24^\>NE30-49-10                       **52.17** (23)   **25.03 ± 0.15**\*   **0.022 ± 0.005**\*
  **(B)**                                                                           
  UAS-*E75* RNAi (GD)                         87.50 (24)       23.56 ± 0. 35        0.078 ± 0.004
  UAS-*E75* RNAi (KK)                         86.90 (23)       23\. 64 ± 0.52       0.081 ± 0.007
  UAS-*E75* RNAi ^JF02257^                    86.36 (22)       23.73 ± 0.32         0.047 ± 0.003
  UAS-*E75* RNAi ^HMS01530^                   90.00 (20)       23.79 ± 0.54         0.042 ± 0.002
  TG^27^\>*E75* RNAi (GD)                     **58.33** (24)   22.84 ± 0.41         **0.031 ± 0.004**\*
  TG^27^\>*E75* RNAi (KK)                     75.00 (24)       22.82 + 0.48         0**.042 ± 0.009**\*
  TG^27^\>*E75* RNAi ^JF02257^                **25.00** (24)   **22.51 ± 0.31**\*   **0.024 ± 0.009**\*
  TG^27^\>*E75* RNAi ^HMS01530^               nd               nd                   nd
  *Pdf\>E75* RNAi (GD)                        73.91 (23)       23.04 ± 0.52         **0.048 ± 0.006**\*
  *Pdf\>E75* RNAi (KK)                        82.61 (23)       23.84 ± 0.49         0.062 ± 0.007
  *Pdf\>E75* RNAi ^JF02257^                   79.17 (24)       23.57 ± 0.47         **0.029 ± 0.005**\*
  *Pdf\>E75* RNAi ^HMS01530^                  **52.38** (21)   22.71 ± 0.75         0.031 ± 0.006
  TUG;*D2*                                    86.96 (23)       23.57 ± 0.14         0.073 ± 0.003
  *Pdf*; D2                                   91.30 (23)       23.84 ± 0.65         0.082 ± 0.004
  TUG; D2\>*E75* RNAi (GD)                    **31.82** (22)   23.03 ± 0.15         **0.012 ± 0.005**\*
  TUG;D2\>*E75* RNAi ^JF02257^                **0** (22)       ar                   ar
  *Pdf;* D2\>-*E75* RNAi (GD)                 **60.00** (20)   23.08 ± 0.34         0.072 ± 0.007
  *Pdf*; D2\>*E75* RNAi ^JF02257^             **58.33** (23)   23.16 ± 0.48         **0.032 ± 0.003**\*
  *E75^Δ51^/+*                                91.67 (24)       23.23±0.23           0.049 ± 0.008
  *E75RNAi ^JF02257^;E75^Δ51^*/+              86.36 (23)       23.78 ± 0.48         0.064 ± 0.004
  *E75RNAi* (GD);*E75^Δ51^*/+                 90.0 (20)        23.85 ± 0.83         0.065 ± 0.007
  *Pdf*\>*E75* RNAi ^JF02257)^/*E75^Δ51^*/+   **40.91** (20)   22.76 ± 0.47         0.036 ± 0.009
  *Pdf*\>*E75* RNAi (GD)/*E75^Δ51^*/+         **60.86** (31)   23.14 ± 0.45         0.057 ± 0.007

D2 =UAS-*dicer*-2; n= number of flies assayed. *Pdf, cry,* TG and TUG refer to Gal4 drivers. Boldface indicates noticeable differences from Gal4 and/or UAS controls. Asterisks indicate significant difference (p\<0.05, unpaired *t*-test). Statistical analysis cannot be conducted for % rhythmic flies. nd= not determined, ar= arrhythmic.

###### 

Circadian behavior of flies with altered EcR expression levels under DD conditions

  \(A\)                                                                                         
  ------------------------ ---------------- --------------------------------------------------- ---------------------------------------------------
  *Pdf*; D2                100 (16)         23.69 ± 0.047                                       0.065 ± 0.008
  TUG; D2                  100 (16)         23.78 ± 0.045                                       0.054 ± 0.008
  UAS-*EcR*-B1^Δ^          100 (14)         24.11 ± 0.075                                       0.135 ± 0.013
  UAS-*EcR*-A RNAi         100 (16)         24.53 ± 0.047                                       0.080 ± 0.007
  *Pdf* \>*EcR*-B1^Δ^      93.75 (16)       **25.32 ± 0.147**[\*](#TFN3){ref-type="table-fn"}   **0.031 ± 0.004**[\*](#TFN3){ref-type="table-fn"}
  TUG \>*EcR*-B1^Δ^        **68.75** (16)   **26.01 ± 0.089**[\*](#TFN3){ref-type="table-fn"}   0.056 ± 0.024
  *Pdf*;D2\>*EcR*-A RNAi   100 (15)         24.24 ± 0.204                                       **0.038 ± 0.004**[\*](#TFN3){ref-type="table-fn"}
  TUG;D2\>*EcR*-A RNAi     93.75 (16)       **25.65 ± 0.149**[\*](#TFN3){ref-type="table-fn"}   0.057 ± 0.009
  **(B)**                                                                                       
  UAS-*EcR*-A              100 (16)         23.81 ± 0.029                                       0.059 ± 0.006
  UAS-*EcR*-B2             100 (13)         23.69 ± 0.076                                       0.035 ± 0.005
  UAS-*EcR*-C              100 (11)         24.16 ± 0.084                                       0.063 ± 0.013
  *Pdf*\>*EcR*-A           **62.5** (16)    24.06 ± 0.205                                       **0.029 ± 0.003**[\*](#TFN3){ref-type="table-fn"}
  TG^27^\>*EcR*-A          93.75 (16)       **27.32 ± 0.092**[\*](#TFN3){ref-type="table-fn"}   **0.026 ± 0.003**[\*](#TFN3){ref-type="table-fn"}
  *Pdf*\>*EcR*-B2          100 (13)         23.65 ± 0.113                                       **0.021 ± 0.003**[\*](#TFN3){ref-type="table-fn"}
  TG^27^\>*EcR*-B2         **50** (14)      **25.14 ± 0.048**[\*](#TFN3){ref-type="table-fn"}   0.040 ± 0.006
  *Pdf*\>*EcR*-C           96.77 (31)       24.59 ± 0.057                                       0.065 ± 0.006
  TG^27^\>*EcR*-C          **40.62** (32)   **25.88 ± 0.397**[\*](#TFN3){ref-type="table-fn"}   **0.029 ± 0.005**[\*](#TFN3){ref-type="table-fn"}

D2 denotes UAS-*dicer*-2, n= number of flies assayed. Values in bold indicate noticeable differences from GAL4 and/or UAS-controls.

Indicates significant difference (p\< 0.05, unpaired *t-*test). Statistical analysis cannot be conducted for % rhythmic flies

###### 

Circadian behavior of flies with low E75 under nutritional stress conditions

  \(A\)                                                                     
  --------------------------- ------------ ---------------- --------------- ---------------------------------------------------
  Iso31                       5% sucrose   97.83 (46)       23.92 ± 0.060   0.062 ± 0.005
  Iso31                       2% sucrose   97.87 (47)       23.89 ± 0.055   0.066 ± 0.005
  Iso31                       1% sucrose   88.89 (45)       23.97 ± 0.114   0.048 ± 0.004
  **(B)**                                                                   
  *E75* RNAi (GD)             5% Sucrose   100 (34)         23.54 ± 0.092   0.041 ± 0.004
  *E75* RNAi (GD)             2% Sucrose   96.88 (32)       24.01 ± 0.135   0.052 ± 0.006
  *E75* RNAi (GD)             1% Sucrose   84.62 (26)       24.07 ± 0.188   0.042 ± 0.004
  TUG                         5% Sucrose   93.75 (16)       23.83 ± 0.161   0.039 ± 0.017
  TUG                         2% Sucrose   100 (16)         23.57 ± 0.125   0.065 ± 0.006
  TUG                         1% Sucrose   93.75 (16)       23.01 ± 0.165   0.048 ± 0.007
  TUG\>*E75* RNAi (GD)        5% Sucrose   **62.5** (16)    24.49 ± 0.42    0.040 ± 0.011
  TUG\>*E75* RNAi (GD)        2% Sucrose   **33.34** (12)   23.63 ± 0.71    0.034 ± 0.006
  TUG\>*E75* RNAi (GD)        1% Sucrose   **6.25** (16)    23.92           0.042
  *Pdf*;D2                    5% Sucrose   100 (19)         23.59 ± 0.08    0.043 ± 0.007
  *Pdf*;D2                    2% Sucrose   81.25 (16)       24.07 ± 0.376   0.054 ± 0.006
  *Pdf*;D2                    1% Sucrose   75 (16)          23.48 ± 0.334   0.042 ± 0.016
  *Pdf*;D2\>*E75* RNAi (GD)   5% Sucrose   **58.82** (34)   23.59 ± 0.142   **0.025 ± 0.003**[\*](#TFN5){ref-type="table-fn"}
  *Pdf*;D2\>*E75* RNAi (GD)   2% Sucrose   **40.74** (27)   23.53 ± 0.164   **0.031 ± 0.008**[\*](#TFN5){ref-type="table-fn"}
  *Pdf*;D2\>*E75* RNAi (GD)   1% Sucrose   **30.43** (23)   23.52 ± 0.150   0.025 ± 0.008

D2 denotes Dicer-2, n= number of flies assayed. Values in bold indicate noticeable differences with respect to UAS and Gal4 controls.

Indicates significant difference (p\< 0.05, unpaired *t*-test). Statistical analysis is not possible for % rhythmic flies.
